http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113943359-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b6902a0af17269020b413646d2a24f3 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2800-101 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43504 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 |
| filingDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2066d7056fc4e446b919387bd47c642b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f652c32b4c70ce740b58aa1fc50cfd0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2eca6b47a6a2afdc97df104ad05417a4 |
| publicationDate | 2022-01-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113943359-A |
| titleOfInvention | A caladine-binding protein ASP-3 with antitumor activity derived from Clam and its structure |
| abstract | The invention relates to a calcium-binding protein ASP-3 with anti-tumor activity and its structure, which is derived from Trichocarpus, and belongs to the field of biotechnology. The recombinant calcium-binding protein contains 200 amino acids, and the full length of the corresponding coding gene nucleotide is 603 bp. The protein acts on the EGFR target of HepG2 tumor cells and inhibits tumor growth. The Trichocarpus calcium-binding protein involved in the present invention can be used in the medicine and health care product industries, and can be used in the research of molecular targeted therapeutic drugs for liver cancer. It can not only make full use of marine anti-tumor protein resources, but also obtain abundant anti-tumor proteins to produce considerable economical benefits. benefit. |
| priorityDate | 2021-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 253.